CATALYST PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Catalyst Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Catalyst Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 119M shares, a 11.9% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 119M +12.7M +11.9% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 119M +12M +11.3% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 118M +12.1M +11.4% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 107M +1.86M +1.77% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 107M +2.54M +2.44% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 107M +3.79M +3.69% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 106M +2.98M +2.9% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 105M +2.27M +2.2% Dec 31, 2022 10-K 2024-02-28
Q3 2022 104M +911K +0.88% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 103M -453K -0.44% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 103M -848K -0.82% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 103M -789K -0.76% Dec 31, 2021 10-K 2023-03-15
Q3 2021 103M -495K -0.48% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 103M -260K -0.25% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 104M +396K +0.38% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 104M +385K +0.37% Dec 31, 2020 10-K 2022-03-16
Q3 2020 104M +607K +0.59% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 103M +493K +0.48% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 103M +604K +0.59% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 103M +658K +0.64% Dec 31, 2019 10-K 2021-03-15
Q3 2019 103M +352K +0.34% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 103M +330K +0.32% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 103M +218K +0.21% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 103M +190K +0.19% Dec 31, 2018 10-K 2020-03-16
Q3 2018 103M +17.5M +20.5% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 103M +18M +21.3% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 103M +19.6M +23.6% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 103M +19.6M +23.6% Dec 31, 2017 10-K 2019-03-18
Q3 2017 85.2M +2.36M +2.85% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 84.6M +1.68M +2.03% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 83M +102K +0.12% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 83M +122K +0.15% Dec 31, 2016 10-K 2018-03-14
Q3 2016 82.9M +176K +0.21% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 82.9M +774K +0.94% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 82.9M +861K +1.05% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 82.9M +13.7M +19.9% Dec 31, 2015 10-K 2017-03-15
Q3 2015 82.7M +15.5M +23.1% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 82.1M +14.9M +22.2% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 82M +27.9M +51.5% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 69.1M +15M +27.7% Dec 31, 2014 10-K 2016-03-15
Q3 2014 67.2M +13.2M +24.4% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 67.2M +25.7M +62% Jun 30, 2014 10-Q 2014-08-13
Q1 2014 54.1M +12.7M +30.7% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 54.1M +12.7M +30.7% Dec 31, 2013 10-K 2015-03-13
Q3 2013 54M +19.2M +55.4% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 41.5M +10.7M +34.9% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 41.4M +16.7M +67.4% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 41.4M +16.7M +67.7% Dec 31, 2012 10-K 2014-03-19
Q3 2012 34.7M +13.1M +60.4% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 30.7M +9.09M +42% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 24.7M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 24.7M +5.31M +27.4% Dec 31, 2011 10-K 2013-04-01
Q3 2011 21.7M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 21.7M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 19.4M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.